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Abstract
Introduction:  Though Gauchers disease (G.D.), a lipid storage disease is most commonly
encountered by the hematologist but we present a case of G.D. type-3 which is rare in Indian
subcontinent.
Case presentation: A 36-year-old Hindu, Indian male patient presented with bony pain, kyphosis,
dragging sensation in the abdomen, dementia and ptosis of the left eyelid for one year. Clinical
examination and history pointed to be a lipid storage disease. Radiological examination showed
bilateral necrosis of the neck of femur. A final diagnosis of G.D. type-3 with bilateral necrosis of the
femur neck was reported after examining the bone marrow smears. Unfortunately, we were unable
to do the enzyme study as the patient was lost in the follow-up.
Conclusion: G.D. type-3 with bilateral necrosis of femur neck is rare in our sub-continent. We
are adding a new case to stress the importance of early recognition by clinical manifestation and
finding of G.C. which is hallmark in the diagnosis of G.D.
Introduction
G.D. an autosomal recessive spingolipid disorder result-
ing from the accumulation of glucocerebrosidase in the
cells of macrophage-monocyte system as a result of a defi-
ciency in lysosomal β-glycosidase [glucocerebrosidase]
which is encoded by the gene on chromosome-1[1].
It was first described by Phillippe Gaucher in 1882, who
thought that the peculiar large cells in the spleen were evi-
dence of a primary neoplasm of spleen [2]. In 1924,
Epstein first recognized the storage of glucocerebroside
[3]. Brandy et al. delineated the metabolic defect, the defi-
ciency of the lysosomal hydrolyse acid, β-glucosidase [4].
G.D. is the most common in Ashkenazi Jewish population
in which the gene frequency is 0.034 with expected birth
frequency 1:1000 [5]. It is also relatively common in the
population isolate in Norrbottenia in Northern Sweden
[6]. In the general population the frequency is rare, occur-
ring in 1:50,000 to 1:1000,000 births as per Genetics
Home reference Website [7].
Case Presentation
A 36-year-old Hindu, Indian male presented in the
department of medicine I.G.M.C. Shimla with complaints
of bony pain, limping, kyphosis, dragging sensation in the
left abdomen and ptosis of the eyelids for about one year
duration. There was a past history of epilepsy and seizure
which is under control for the last twenty years. The gen-
eral physical examination was normal. The haematologi-
cal investigation found mild aneamia, total lecocyte
count: 4,000/cumm, and platelets were 1.5 lakhs/cumm.
Peripheral smear findings showed mild dimorphic ane-
mia with eosinophilia. Bone marrow examination found
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particulate, cellular smears M:E: 3:1. Erythropoiesis was
dimorphic. Megakaryocytes seen in adequate number and
function. Myelogram showed myeloblast 03%, promyelo-
cyte 01%, myelocyte 10%, metamyelocyte 20%, plasma
cell 01%, polymorphs 47%, lymphocytes10%, eosi-
nophills 08%. In addition, B.M. showed large number of
large cells 30 to 100 microns in diameter having one to
multiple, centrally or eccentrically placed nuclei with pale,
blue-gray cytoplasm having characteristic fibrally and stri-
ated pattern [Fig 1 &2]. These cells stained strongly with
P.A.S staining [Fig 3] and were Sudan Black negative.
Keeping in view, the clinical presentation and the pres-
ence of Gaucher cells in the B.M., the G.C. infiltration into
the B.M. with eosinophilia was suggested.
Discussion
There are three clinical subtypes of G.D. that has been
delineated by the absence or presence and progression of
neurologic involvement. These are: Type 1 (the adult,
non-neuronopathic form) occurring in children as well as
adults with at least one mild mutation. Type -2 (the infan-
tile or acute neuronopathic form) which is exceeding rare
and characterized by rapid neurologic deterioration and
early death. It does not occur predominantly in Jewish
families.Type-3 (juvenile or Norrbotten form) is a well-
defined subacute neuronopathic disorder with late onset
of neurologic symptoms and has better prognosis than
type-2.
The clinical course of G.D. depends on the clinical sub-
types. Patients with type-1 disease have a broad spectrum
of clinical expression in part due to combination of differ-
ent mutant alleles. Onset of clinical manifestations are:
splenomegaly, bone involvement, bone pain, pathologi-
cal bone fracture, easy bruisability due to thrombocytope-
nia, chronic fatigue secondary to anaemia, hepatomegaly
with or without elevated liver function tests. Occasionally,
patients present with pulmonary involvement. Patients
with a milder form of the disease present later in the life
with haematological or skeletal complaints and/or have
splenomegaly on routine examination. Children with
massive splenomegaly are short statured due to increased
metabolism by the enlarged spleen. Although the disease
is progressive in the adults, it is compatible with long life.
Type-2 disease is rare and panethic in distribution and is
characterised by a rapid neurodegenerative course with
extensive visceral involvement and death within first two
years of life. The disease is present in infancy with
Bone marrow smear showing numerous Gaucher cells-MGG  ×10 Figure 1
Bone marrow smear showing numerous Gaucher 
cells-MGG ×10.
Bone marrow smear showing Gaucher cell Figure 2
Bone marrow smear showing Gaucher cell. The cyto-
plasm has a fibrillary and striated appearance with nuclei 
small and eccentric in location MGG ×100
Bone marrow smear showing Gaucher cells strongly positive  with PAS reaction ×100 Figure 3
Bone marrow smear showing Gaucher cells strongly 
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increased tone, strabismus, organomegaly, failure to
thrive and laryngospasm.
Type-3 disease presents with neurological involvement in
addition to organomegaly and bony manifestations.
G.D. should be considered in the differential diagnosis of
patients with unexplained splenomegaly with an
extended period of time or easy bruisability or bone pain.
B.M. examination is the hallmark for the diagnosis of G.D
however, all suspects should be confirmed by demonstrat-
ing deficient acid β-glucosidase activity in isolated leuko-
cytes [8] or cultured fibroblasts [9] or by demonstrating
the presence of known Gaucher mutations in the patients
DNA.
Pseudo-Gaucher cells may be found in the marrow of
some patients with CML, type II congenital dyserythropoi-
etic anaemia, thalassemia, Hodgkin lymphoma, multiple
myeloma and AIDS. These patients do not lack the capac-
ity to catabolise glucocerbroside [10] but the great inflow
of glucoside in to phagocytic cells exceeds their normal
capacity to hydrolyze this glycolipid. Prenatal diagnosis of
G.D. is established by examining cultured amniocentesis
cells for their β-glucosidase activity [9] or by examining
amniocentesis or chorionic villus DNA for mutations. A
monoclonal gammopathy is present with chronic G.D.
and may be associated with a marrow plasmocytosis [11].
The coincidence of multiple myeloma, plasmacytoid lym-
phoma and G.D. has also been reported [12].
Despite its rarity in India, we present this case to stress the
importance of clinical presentation and B.M. finding in
the diagnosis of G.D. This emphasis the relevance of an
early detection of the disease.
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